Double maintains 1 strategies that include RLAY - Relay Therapeutics, Inc.
Current Value
$2.801 Year Return
Current Value
$2.801 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 52.13% | $4.85B | 0.35% |
GNOM | 51.95% | $40.65M | 0.5% |
PBE | 50.67% | $214.12M | 0.58% |
IBB | 49.89% | $5.22B | 0.45% |
FBT | 46.99% | $994.71M | 0.56% |
ARKG | 46.59% | $944.78M | 0.75% |
KJUL | 45.56% | $113.35M | 0.79% |
PTH | 45.32% | $96.56M | 0.6% |
IWO | 45.04% | $11.36B | 0.24% |
ISCG | 44.64% | $645.00M | 0.06% |
ROBO | 43.95% | $983.03M | 0.95% |
SMOT | 43.88% | $363.89M | 0.49% |
IWM | 43.78% | $63.95B | 0.19% |
VTWO | 43.77% | $12.07B | 0.07% |
XT | 43.70% | $3.24B | 0.46% |
IWC | 43.59% | $766.88M | 0.6% |
QQQJ | 43.58% | $610.08M | 0.15% |
CFA | 43.55% | $524.37M | 0.35% |
BBH | 43.44% | $327.42M | 0.35% |
KOMP | 43.43% | $2.20B | 0.2% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IBMN | 0.04% | $446.12M | 0.18% |
FLDR | 0.05% | $841.44M | 0.15% |
FLIA | 0.06% | $670.20M | 0.25% |
STIP | 0.10% | $11.88B | 0.03% |
CGMU | 0.11% | $3.10B | 0.27% |
HYMB | -0.13% | $2.53B | 0.35% |
FMF | -0.14% | $153.73M | 0.95% |
DBE | -0.17% | $48.48M | 0.77% |
IBTF | 0.19% | $2.12B | 0.07% |
NUBD | -0.22% | $388.33M | 0.16% |
BILZ | -0.23% | $876.85M | 0.14% |
TFI | 0.27% | $3.15B | 0.23% |
FLCB | 0.33% | $2.52B | 0.15% |
TIPX | -0.37% | $1.64B | 0.15% |
LGOV | -0.38% | $684.47M | 0.67% |
HYD | 0.47% | $3.37B | 0.32% |
JMBS | 0.47% | $5.40B | 0.22% |
CARY | -0.47% | $347.36M | 0.8% |
UDN | 0.55% | $137.74M | 0.78% |
GVI | 0.56% | $3.37B | 0.2% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ZCMD | 0.10% | $32.45M | -11.38% | 0.00% |
CYCN | 0.15% | $9.37M | +2.39% | 0.00% |
STG | -0.18% | $27.05M | -37.35% | 0.00% |
OCFT | -0.21% | $265.28M | +232.26% | 0.00% |
GO | 0.26% | $1.37B | -35.98% | 0.00% |
KMB | 0.32% | $45.57B | +1.99% | 3.58% |
CMTL | 0.33% | $50.48M | -14.43% | 0.00% |
VIV | 0.37% | $16.11B | +13.49% | 0.00% |
ED | -0.48% | $36.75B | +5.26% | 3.28% |
BTCT | 0.50% | $25.35M | +93.08% | 0.00% |
DG | -0.79% | $20.45B | -36.56% | 2.55% |
LRN | 0.80% | $6.69B | +118.03% | 0.00% |
KR | -1.06% | $44.68B | +24.17% | 1.89% |
PPC | -1.14% | $11.21B | +41.54% | 0.00% |
PSQH | -1.21% | $89.26M | -49.87% | 0.00% |
CCEC | 1.23% | $1.02B | +3.91% | 2.71% |
MCK | 1.24% | $88.42B | +27.17% | 0.39% |
TIMB | 1.35% | $8.38B | +3.30% | 2.99% |
TEF | 1.47% | $27.20B | +8.80% | 6.44% |
LFVN | 1.47% | $158.74M | +75.02% | 1.27% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TAIL | -36.75% | $140.49M | 0.59% |
VIXY | -34.71% | $109.64M | 0.85% |
BTAL | -28.16% | $361.41M | 1.43% |
IVOL | -14.70% | $353.94M | 1.02% |
TPMN | -13.30% | $31.54M | 0.65% |
BIL | -10.61% | $45.95B | 0.1356% |
CTA | -10.28% | $1.05B | 0.76% |
ULST | -9.97% | $637.77M | 0.2% |
XONE | -9.96% | $603.24M | 0.03% |
SPTS | -9.43% | $5.76B | 0.03% |
TFLO | -8.89% | $7.06B | 0.15% |
FTSD | -8.78% | $212.46M | 0.25% |
FTSM | -8.49% | $6.54B | 0.45% |
UTWO | -8.39% | $387.71M | 0.15% |
SHYM | -7.78% | $322.93M | 0.35% |
IBTG | -7.76% | $1.88B | 0.07% |
SCHO | -7.40% | $10.87B | 0.03% |
VGSH | -7.29% | $22.38B | 0.03% |
FXY | -6.82% | $838.61M | 0.4% |
XHLF | -6.38% | $1.46B | 0.03% |
Yahoo
We recently published a list of 10 Best Low Priced Biotech Stocks to Buy Now. In this article, we are going to take a look at where Relay Therapeutics, Inc. (NASDAQ:RLAY) stands against other best low priced biotech stocks to buy now. Is Now the Time to Buy Biotech Stocks? On May 8, Michael Yee, […]
Yahoo
CAMBRIDGE, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today announced that management will participate in two upcoming fireside chats: BoA Securities 2025 Healthcare Conference on Wednesday, May 14, 2025 at 3:40 p.m. PTTD Cowen’s 6th Annual Oncology Innovation Summit on Tuesday, May 27, 2025 at 3:30 p.m. E
Finnhub
Presenter SpeechJason Gerberry Going here with our next company presenter at the BofA Annual Healthcare Conference. Pleased to be introducing Relay Therapeutics and Pete Rahmer, Chief Corporate...
Yahoo
We came across a bullish thesis on Relay Therapeutics, Inc. (RLAY) on Substack by Steve Wagner. In this article, we will summarize the bulls’ thesis on RLAY. Relay Therapeutics, Inc. (RLAY)’s share was trading at $3.15 as of May 6th. Relay Therapeutics (RLAY) is taking decisive steps to secure its future by doubling down on its lead […]
Yahoo
Cash runway extended into 2029 Initiation of Phase 3 ReDiscover-2 trial on track for mid-2025 Initiated Phase 1 RLY-2608 vascular malformations clinical trial in Q1 Extended cash runway expected to fully fund the Company meaningfully past topline data for ReDiscover-2 trial and through clinical proof-of-concept data in Vascular Malformations Approximately $710 million in cash, cash equivalents and investments at end of Q1 2025 CAMBRIDGE, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics
Yahoo
CAMBRIDGE, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, will report first quarter 2025 financial results and corporate highlights after the U.S. financial markets close on Monday, May 5, 2025. About Relay Therapeutics Relay Therapeutics (Nasdaq: RLAY) is a clinical-stage precision medicine company transfor
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
LITB | -12.46% | $21.28M | -72.45% | 0.00% |
CBOE | -10.73% | $22.95B | +20.67% | 1.12% |
CME | -7.93% | $98.74B | +28.80% | 3.84% |
ACI | -5.44% | $12.61B | +4.78% | 2.47% |
NEUE | -4.94% | $62.05M | +13.56% | 0.00% |
VHC | -4.77% | $34.69M | +74.89% | 0.00% |
VSA | -4.69% | $7.04M | -49.24% | 0.00% |
K | -4.16% | $28.49B | +32.17% | 2.77% |
FMTO | -3.67% | $45.74M | -99.96% | 0.00% |
VSTA | -2.51% | $326.82M | +11.64% | 0.00% |
CL | -2.41% | $72.64B | -5.18% | 2.25% |
AGRO | -2.27% | $891.94M | -18.01% | 3.91% |
MNOV | -2.00% | $68.17M | -2.80% | 0.00% |
PLCE | -1.89% | $138.61M | -49.44% | 0.00% |
MSIF | -1.58% | $715.25M | +28.42% | 7.05% |
HEES | -1.56% | $3.52B | +99.54% | 1.15% |
PSQH | -1.21% | $89.26M | -49.87% | 0.00% |
PPC | -1.14% | $11.21B | +41.54% | 0.00% |
KR | -1.06% | $44.68B | +24.17% | 1.89% |
DG | -0.79% | $20.45B | -36.56% | 2.55% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
XNCR | 53.30% | $583.60M | -63.49% | 0.00% |
ZWS | 49.25% | $6.23B | +14.37% | 0.92% |
SHC | 44.63% | $3.62B | +11.66% | 0.00% |
DHR | 44.35% | $136.66B | -27.90% | 0.60% |
NEU | 44.11% | $6.10B | +16.03% | 1.58% |
IMNM | 44.05% | $696.10M | -44.44% | 0.00% |
CSWI | 42.77% | $5.49B | +34.75% | 0.29% |
RXRX | 42.71% | $1.73B | -55.31% | 0.00% |
KYMR | 42.67% | $1.95B | -15.67% | 0.00% |
BDTX | 42.31% | $109.74M | -63.17% | 0.00% |
CRNX | 42.23% | $2.92B | -39.88% | 0.00% |
FTV | 41.86% | $24.63B | -6.27% | 0.44% |
RVMD | 41.79% | $7.35B | +1.15% | 0.00% |
TVTX | 41.64% | $1.88B | +216.14% | 0.00% |
DOV | 41.34% | $25.28B | +0.11% | 1.11% |
RCKT | 41.27% | $724.54M | -71.26% | 0.00% |
MGNX | 40.73% | $97.16M | -69.92% | 0.00% |
RVTY | 40.71% | $10.66B | -16.65% | 0.31% |
ALEC | 40.36% | $110.49M | -79.87% | 0.00% |
ITT | 40.09% | $11.82B | +8.44% | 0.87% |